AAAAAA

   
Results: 1-3 |
Results: 3
Prevention of venous thromboembolic disease following primary total knee arthroplasty - A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin
Authors: Fitzgerald, RH Spiro, TE Trowbridge, AA Gardiner, GA Whitsett, TL O'Connell, MB Ohar, JA Young, TR
Citation: Rh. Fitzgerald et al., Prevention of venous thromboembolic disease following primary total knee arthroplasty - A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin, J BONE-AM V, 83A(6), 2001, pp. 900-906
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease
Authors: Merli, G Spiro, TE Olsson, CG Abildgaard, U Davidson, BL Eldor, A Elias, D Grigg, A Musset, D Rodgers, GM Trowbridge, AA Yusen, RD Zawilska, K
Citation: G. Merli et al., Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease, ANN INT MED, 134(3), 2001, pp. 191-202
Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement - A randomized, double-blind, placebo-controlled trial
Authors: Heit, JA Elliott, CG Trowbridge, AA Morrey, BF Gent, M Hirsh, J
Citation: Ja. Heit et al., Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement - A randomized, double-blind, placebo-controlled trial, ANN INT MED, 132(11), 2000, pp. 853
Risultati: 1-3 |